Journal Mobile Options
Table of Contents
Vol. 57, No. 3, 2004
Issue release date: March 2004
Gynecol Obstet Invest 2004;57:157–173
(DOI:10.1159/000076374)

The Link between Exposure to Dioxin and Endometriosis: A Critical Reappraisal of Primate Data

Guo S.-W.
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisc., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Endometriosis is a common and enigmatic disease affecting women of reproductive age. In 1993, Dr. Sherry Rier and her colleagues reported a serendipitous finding that quickly sent a shock wave through the endometriosis research community. They found that rhesus monkeys exposed daily for 4 years to dioxin developed endometriosis, with incidence and severity related to dose. The study prompted more animal and epidemiologic studies regarding the link between dioxin exposure and endometriosis. Yet, 10 years after the first piece of evidence was reported, the primate data are still equivocal, and the human data supporting the dioxin-endometriosis association are scanty and conflicting. While many reviewers of the subject recognize the need for more data, other reviewers tend to discount negative studies when reviewing positive studies. In this paper, a critical reappraisal of all evidence from human and primate data is presented. While there is evidence suggesting that exposure to dioxin may facilitate the short-term survival of endometrial implants in non-human primates, this evidence is not supported by both human and non-human primate studies evaluating the relationship between dioxin exposure and the development of spontaneous endometriosis. Weighing all converging evidence, it seems that there are no solid, credible data available at this moment to support the hypothesis that dioxin exposure may lead to the development of endometriosis.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Zondervan KT, Cardon LR, Kennedy SH: The genetic basis of endometriosis. Curr Opin Obstet Gynecol 2001;13:309–314.
  2. Zeyneloglu HB, Arici A, Olive DL: Environmental toxins and endometriosis. Obstet Gynecol Clin North Am 1997;24:307–329.
  3. Yoshida K, Ikeda S, Nakanishi J: Assessment of human health risk of dioxins in Japan. Chemosphere 2000;40:177–185.
  4. Yang JZ, Agarwal SK, Foster WG: Subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin modulates the pathophysiology of endometriosis in the cynomolgus monkey. Toxicol Sci 2000;56:374–381.
  5. Wood DH, Yochmowitz MG, Salmon YL, Eason RL, Boster RA: Proton irradiation and endometriosis. Aviat Space Environ Med 1983;54:718–724.
  6. Wood DH: Long-term mortality and cancer risk in irradiated rhesus monkeys. Radiat Res 1991;126:132–140.
  7. Wissing M: Dioxins: Current knowledge about health effects (in French). Rev Méd Brux 1998;19:A367–A371.
  8. Watanabe T, Imoto I, Kosugi Y, Fukuda Y, Mimura J, Fujii Y, Isaka K, Takayama M, Sato A, Inazawa J: Human arylhydrocarbon receptor repressor (AHRR) gene: Genomic structure and analysis of polymorphism in endometriosis. J Hum Genet 2001;46:342–346.
  9. Vercellini P, De Giorgi O, Aimi G, Panazza S, Uglietti A, Crosignani PG: Menstrual characteristics in women with and without endometriosis. Obstet Gynecol 1997;90:264–268.
  10. Tukey JW: Some thoughts on clinical trials, especially problems of multiplicity. Science 1977;198:679–684.
  11. Tsutsumi O, Momoeda M, Takai Y, Ono M, Taketani Y: Breast-fed infants, possibly exposed to dioxins in milk, have unexpectedly lower incidence of endometriosis in adult life. Int J Gynaecol Obstet 2000;68:151–153.
  12. Thornton J: Pandora’s Poison: Chlorine, Health and a New Environmental Strategy. Boston, MIT Press, 2000.
  13. TeLinda RW, Scott RB: Experimental endometriosis. Am J Obstet Gynecol 1950;60:1147–1173.

    External Resources

  14. Sterne JAC, Egger M, Smith GD: Investigating and dealing with publication and other biases; in Egger M, Smith GD, Altman DG (eds): Systematic Reviews in Health Care: Meta-Analysis in Context. London, BMJ Books, 2001, pp 189–208.
  15. Scientific Committee on Food, European Commission: Opinion of the Scientific Committee on Food on the risk assessment of dioxins and dioxin-like PCBs in food. 2000. http://europa.eu.int/comm/food/fs/sc/scf/out78_en.pdf and 2001 http://europa.eu.int/comm/food/fs/sc/scf/out90_en.pdf
  16. Scialli AR: Tampons, dioxins and endometriosis. Reprod Toxicol 2001;15:231–238.
  17. Schantz SL, Ferguson SA, Bowman RE: Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on behavior of monkeys in peer groups. Neurotoxicol Teratol 1992;14:433–446.
  18. Sanfilippo JS, Wakim NG, Schikler KN, Yussman MA: Endometriosis in association with uterine anomaly. Am J Obstet Gynecol 1984;154:39–43.
  19. Sampson JA: Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927;14:422–469.
  20. Rothman KJ, Greenland S: Causation and causal inference; in Rothman KJ, Greenland S (eds): Modern Epidemiology, ed 2. Philadelphia, Lippincott-Raven, 1998, pp 7–28.
  21. Rosner B: Fundamentals of Biostatistics. Boston, Duxbury Press, 1986.
  22. Rosenthal R: The ‘file drawer problem’ and tolerance for null results. Psychol Bull 1979;86:638–641.

    External Resources

  23. Ringvold S, Rottingen JA: Environmental pollutants with hormonal effects. Is estrogen theory a good model? (in Norwegian) Tidsskr Nor Lægeforen 1997;117:66–70.
  24. Rier SE, Turner WE, Martin DC, Morris R, Lucier GW, Clark GC: Serum levels of TCDD and dioxin-like chemicals in rhesus monkeys chronically exposed to dioxin: Correlation of increased serum PCB levels with endometriosis. Toxicol Sci 2001b;59:147–159.
  25. Rier SE, Martin DC, Bowman RE, Dmowski WP, Becker JL: Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol 1993;21:433–441.
  26. Rier SE, Martin DC, Bowman RE, Becker JL: Immunoresponsiveness in endometriosis: Implications of estrogenic toxicants. Environ Health Perspect 1995;103(suppl 7):151–156.
  27. Rier SE, Foster WG: Environmental dioxins and endometriosis. Semin Reprod Med 2003;21:145–154.
  28. Rier SE, Foster WG: Environmental dioxins and endometriosis. Toxicol Sci 2002;70:161–170.
  29. Rier SE, Coe CL, Lemieux AM, Martin DC, Morris R, Lucier GW, Clark GC: Increased tumor necrosis factor-α production by peripheral blood leukocytes from TCDD-exposed rhesus monkeys. Toxicol Sci 2001a;60:327–337.
  30. Rier SE: The potential role of exposure to environmental toxicants in the pathophysiology of endometriosis. Ann NY Acad Sci 2002;955:201–212, 230–232, 396–406.
  31. Rier SE: Reply to Hitchin. Toxicol Sci 1994;23:141–142.
  32. Pauwels A, Schepens PJ, D’Hooghe T, Delbeke L, Dhont M, Brouwer A, Weyler J: The risk of endometriosis and exposure to dioxins and polychlorinated biphenyls: A case-control study of infertile women. Hum Reprod 2001;16:2050–2055.
  33. Osteen KG, Sierra-Rivera E: Does disruption of immune and endocrine systems by environmental toxins contribute to development of endometriosis? Semin Reprod Endocrinol 1997;15:301–308.
  34. Olive DL, Schwartz LB: Endometriosis. N Engl J Med 1993;328:1759–1769.
  35. Olive DL, Lindheim SR, Pritts EA: Endometriosis and infertility: What do we do for each stage? Curr Womens Health Rep 2003;3:389–394.
  36. Olive DL, Henderson DY: Endometriosis and mullerian anomalies. Obstet Gynecol 1987;69:412–415.
  37. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, Tohyama C, Krust A, Mimura J, Chambon P, Yanagisawa J, Fujii-Kuriyama Y, Kato S: Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 2003;423:545–550.
  38. Moyé LA: Random research. Circulation 2001;103:3150–3153.

    External Resources

  39. Mills JL: Data torturing. N Engl J Med 1993;329:1196–1199.
  40. McCann TO, Myers RE: Endometriosis in rhesus monkeys. Am J Obstet Gynecol 1970;106:516–523.
  41. Mayani A, Barel S, Soback S, Almagor M: Dioxin concentrations in women with endometriosis. Hum Reprod 1997;12:373–375.
  42. Martin DC: Laparoscopic Appearances of Endometriosis, Color Atlas, ed 2. Memphis, Resurge Press, 1991, pp 5–6.
  43. Mann DR, Collins DC, Smith MM, Kessler MJ, Gould KG: Treatment of endometriosis in monkeys: Effectiveness of continuous infusion of a gonadotropin-releasing hormone agonist compared to treatment with a progestational steroid. J Clin Endocrinol Metab 1986;63:1277–1283.
  44. Mahutte NG, Arici A: Medical management of endometriosis-associated pain. Obstet Gynecol Clin North Am 2003;30:133–150.
  45. Mahmood TA, Templeton AA: Prevalence and genesis of endometriosis. Hum Reprod 1991;6:544–549.
  46. Longnecker MP, Rogan WJ, Lucier G: The human health effects of DDT (dichlorodiphenyltrichloroethane) and PCBS (polychlorinated biphenyls) and an overview of organochlorines in public health. Annu Rev Public Health 1997;18:211–244.
  47. Liu DTY, Hitchcock A: Endometriosis: Its association with retrograde menstruation, dysmenorrhoea and tubal pathology. Br J Obstet Gynaecol 1986;93:859–862.
  48. Lindberg BS, Busch C: Endometriosis in rhesus monkeys. Ups J Med Sci 1984;89:129–134.
  49. Lebel G, Dodin S, Ayotte P, Marcoux S, Ferron LA, Dewailly E: Organochlorine exposure and the risk of endometriosis. Fertil Steril 1998;69:221–228.
  50. Koninckx PR, Braet P, Kennedy SH, Barlow DH: Dioxin pollution and endometriosis in Belgium. Hum Reprod 1994;9:1001–1002.
  51. Koninckx PR: The physiopathology of endometriosis: Pollution and dioxin. Gynecol Obstet Invest 1999;47(suppl 1):47–50.
  52. Kogevinas M: Human health effects of dioxins: Cancer, reproductive and endocrine system effects. Hum Reprod Update 2001;7:331–339.
  53. Kociba RJ, Keyes DG, Beyer JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Frauson LE, Park CN, Barnard SD, Hummel RA, Humiston CG: Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol 1978;46:279–303.
  54. Kennedy S: The genetics of endometriosis. J Reprod Med 1998;43(suppl):263–268.
  55. Jonckheere AR: Distribution-free k-sample test against ordered alternatives. Biometrika 1954;41:133–145.
  56. Holt VL, Weiss NS: Recommendations for the design of epidemiologic studies of endometriosis. Epidemiology 2000;11:654–659.
  57. Holloway M: An epidemic ignored. Endometriosis linked to dioxin and immunologic dysfunction. Sci Am 1994;270:24–26.
  58. Hitchin D: Re: Concerns about statistical methods. Fundam Appl Toxicol 1994;23:141–142.
  59. Hill AB: The environment and disease: Association or causation? Proc R Soc Med 1965;58:295–300.
  60. Heimler I, Rawlins RG, Owen H, Hutz RJ: Dioxin perturbs, in a dose- and time-dependent fashion, steroid secretion, and induces apoptosis of human luteinized granulosa cells. Endocrinology 1998;139:4373–4379.
  61. Hedges L, Olkin I: Statistical Methods for Meta-Analysis. Orlando, Academic Press, 1985.
  62. Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM: Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984;64:151–154.
  63. Greenhalgh T: How to read a paper. Papers that report diagnostic or screening tests. BMJ 1997;315:540–543. Erratum in: BMJ 1997;315:942. BMJ 1998;316:225.
  64. Gray LE Jr, Ostby JS: In utero 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters reproductive morphology and function in female rat offspring. Toxicol Appl Pharmacol 1995;133:285–294.
  65. Gibbs LM: Dying from Dioxin: A Citizen’s Guide to Reclaiming Our Health and Rebuilding Democracy. Boston, South End Press, 1995.
  66. Gibbons A: Dioxin tied to endometriosis. Science 1993;262:1373.
  67. Gerhard I, Runnebaum B: The limits of hormone substitution in pollutant exposure and fertility disorders (in German). Zentralbl Gynäkol 1992;114:593–602.
  68. Freemantle N: Interpreting the results of secondary end points and subgroup analyses in clinical trials: Should we lock the crazy aunt in the attic? BMJ 2001;322:989–991.
  69. Foster WG, Agarwal SK: Environmental contaminants and dietary factors in endometriosis. Ann NY Acad Sci 2002;955:213–232, 396–406.
  70. Foster WG: Do environmental contaminants adversely affect human reproductive physiology? J Obstet Gynaecol Can 2003;25:33–44.
  71. Fedele L, Parazzini F, Bianchi S, Arcaini L, Candiani G: Stage and localization of pelvic endometriosis and pain. Fertil Steril 1990;53:155–158.
  72. Farquhar CM: Extracts from the ‘clinical evidence’. Endometriosis. BMJ 2000;320:1449–1452.
  73. Farland W, Schaum J, Winters D, Lorber M, Cleverly D, Rodan B, Tuxen L, DeVito M, Birnbaum L: US EPA’s risk characterization of dioxin and related compounds. Organohalogen Compounds 2000;48:248–251.
  74. Fanton JW, Golden JG: Radiation-induced endometriosis in Macaca mulatta. Radiat Res 1991;126:141–146.
  75. Eskenazi B, Warner ML: Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997;24:235–258.
  76. Eskenazi B, Mocarelli P, Warner M, Samuels S, Vercellini P, Olive D, Needham LL, Patterson DG Jr, Brambilla P, Gavoni N, Casalini S, Panazza S, Turner W, Gerthoux PM: Serum dioxin concentrations and endometriosis: A cohort study in Seveso, Italy. Environ Health Perspect 2002;110:629–634.
  77. Dmowski WP, Braun D, Gebel H: The immune system in endometriosis; in Thomas EJ, Rock JA (eds): Modern Approaches to Endometriosis. Boston, Kluver Academic, 1991, pp 97–111.
  78. Dmowski WP: Immunological aspects of endometriosis. Int J Gynaecol Obstet 1995;50(suppl 1):3–10.
  79. D’Hooghe TM, Debrock S, Meuleman C, Hill JA, Mwenda JM: Future directions in endometriosis research. Obstet Gynecol Clin North Am 2003;30:221–244.
  80. D’Hooghe TM, Bambra CS, Raeymaekers BM, De Jonge I, Lauweryns JM, Koninckx PR: Intrapelvic injection of menstrual endometrium causes endometriosis in baboons (Papio cynocephalus and Papio anubis). Am J Obstet Gynecol 1995;173:125–134.
  81. D’Hooghe TM, Bambra CS, De Jonge I, Lauweryns JM, Koninckx PR: The prevalence of spontaneous endometriosis in the baboon (Papio anubis, Papio cynocephalus) increases with the duration of captivity. Acta Obstet Gynecol Scand 1996;75:98–101.
  82. Darrow SL, Vena JE, Batt RE, Zielezny MA, Michalek AM, Selman S: Menstrual cycle characteristics and the risk of endometriosis. Epidemiology 1993;4:135–142.
  83. Crosignani PG, Vercellini P: New clinical guidelines are needed for the treatment of endometriosis. Hum Reprod 1994;9:2205–2206.
  84. Cramer DW, Wilson E, Stillman RJ, Berger MJ, Belisle S, Schiff I, Albrecht B, Gibson M, Stadel BV, Schoenbaum SC: The relation of endometriosis to menstrual characteristics, smoking and exercise. JAMA 1986;255:1904–1908.
  85. Cramer DW, Missmer SA: The epidemiology of endometriosis. Ann NY Acad Sci 2002;955:11–22.
  86. Colborn T, Dumanoski D, Myers JP: Our Stolen Future: Are We Threatening Our Fertility, Intelligence and Survival? A Scientific Detective Story. New York, Dutton/Plume, 1996.
  87. Cochran WC, Cox GM: Experimental Designs. New York, Wiley, 1957.
  88. Canis M, Chassagne J, Dechelotte P, Bassil S, Wattiez A, Pouly JL, Mage G, Bruhat MA: Experimental endometriosis: Spontaneous evolution of surgically induced peritoneal implants in rhesus monkeys; in Coutinho EM, Spinola P, de Moura LH (eds): Progress in the Management of Endometriosis. New York, Parthenon, 1995, pp 245–253.
  89. Campbell JS, Wong J, Tryphonas L, Arnold DL, Nera E, Cross B, LaBrossière E: Is simian endometriosis an effect of immunotoxicity? Ontario Association of Pathology, Annual Meeting, Oct 4, London, Ont 1985.
  90. Bruner-Tran KL, Rier SE, Eisenberg E, Osteen KG: The potential role of environmental toxins in the pathophysiology of endometriosis. Gynecol Obstet Invest 1999;48(suppl 1):45–56.
  91. Boyd J, Clark G, Walmer D, Patterson D, Needham L, Lucier G: Endometriosis and the environment: Biomarkers of toxin exposure (abstract). Endometriosis 2000 Conference, May 15, Bethesda 1995.
  92. Bowman RE, Schantz SL, Weerasinghe NCA, Gross M, Barsotti D: Chronic dietary intake of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) at 5 or 25 parts per trillion in the monkey: TCDD kinetics and dose-effect estimates of reproductive toxicity. Chemosphere 1989;18:243–252.

    External Resources

  93. Boling RO, Abbasi R, Ackerman G, Schipul AH Jr, Chaney SA: Disability from endometriosis in the United States Army. J Reprod Med 1988;33:49–52.
  94. Bland JM, Altman DG: Multiple significance tests: The Bonferroni method. BMJ 1995;310:170–172.
  95. Birnbaum LS, Cummings AM: Dioxins and endometriosis: A plausible hypothesis. Environ Health Perspect 2002;110:15–21.
  96. Birnbaum LS: Evidence for the role of the Ah receptor in response to dioxin; in Spitzer HL, Slaga TJ, Greenlee WF, McClain M (eds): Receptor-mediated biological processes: Implications for evaluating carcinogenesis. Prog Clin Biol Res. New York, Wiley Liss, 1994b, vol 387, pp 139–154.
  97. Birnbaum LS: The mechanism of dioxin toxicity: Relationship to risk assessment. Environ Health Perspect 1994a;102(suppl 9):157–167.
  98. Ballweg ML: The Endometriosis Sourcebook. Milwaukee, Endometriosis Association, 1995.
  99. Arumugam K, Lim JM: Menstrual characteristics associated with endometriosis. Br J Obstet Gynaecol 1997;104:948–950.
  100. Arnold DL, Nera EA, Stapley R, Tolnai G, Claman P, Hayward S, Tryphonas H, Bryce F: Prevalence of endometriosis in rhesus (Macaca mulatta) monkeys ingesting PCB (Aroclor 1254): Review and evaluation. Fundam Appl Toxicol 1996;31:42–55.
  101. Arnold DL, Krewski D, Munro IC: Saccharin: A toxicological and historical perspective. Toxicology 1983;27:179–256.
  102. Anonymous: Dioxin and endometriosis. Environ Health Perspect 1993;101:571–572.
  103. Ahlborg UG, Lipworth L, Titus-Ernstoff L, Hsieh CC, Hanberg A, Baron J, Trichopoulos D, Adami HO: Organochlorine compounds in relation to breast cancer, endometrial cancer and endometriosis: An assessment of the biological and epidemiological evidence. Crit Rev Toxicol 1995;25:463–531.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50